Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Download search results Subscribe to news feed Your filters: cql: author="Agoston, Peter" or (type any "bookEditor journalEditor issueEditor" and editor="Agoston, ... Add to list Journal Article A1 NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act. In. Sarc) : a multicentre, phase 2-3, randomised, controlled trial Sylvie Bonvalot, Piotr L Rutkowski, Juliette Thariat, Sebastien Carrere, Anne Ducassou, Marie-Pierre Sunyach, Peter Agoston, Angela Hong, Augustin Mervoyer, Marco Rastrelli, et al. (2019) LANCET ONCOLOGY. 20(8). p.1148-1159